Literature DB >> 9715375

Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision.

F M Ewing1, I J Deary, M W Strachan, B M Frier.   

Abstract

Contrast sensitivity testing, in common with color vision (another test of psychophysical function), demonstrates significant changes in diabetic subjects compared with nondiabetic controls, and there is some evidence for a relationship with grade of retinopathy. Changes in contrast sensitivity have been demonstrated in children and adults with diabetes of short duration, and some evidence exists for a correlation with poor glycemic control, although prospective studies are required to assess this relationship over a longer time period. Although both color vision and contrast sensitivity demonstrate similar patterns, studies that directly compare the two tests suggest that measurement of contrast sensitivity is the more sensitive and specific.

Entities:  

Mesh:

Year:  1998        PMID: 9715375     DOI: 10.1210/edrv.19.4.0340

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  30 in total

Review 1.  Research Progress in MRI of the Visual Pathway in Diabetic Retinopathy.

Authors:  Yu-Min Li; Hong-Mei Zhou; Xiang-Yang Xu; He-Shui Shi
Journal:  Curr Med Sci       Date:  2018-12-07

Review 2.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

3.  Diagnosing and monitoring diabetic macular edema: structural and functional tests.

Authors:  Edoardo Midena; Stela Vujosevic
Journal:  Int Ophthalmol       Date:  2012-05-23       Impact factor: 2.031

4.  Protective Effects of Adeno-associated Virus Mediated Brain-derived Neurotrophic Factor Expression on Retinal Ganglion Cells in Diabetic Rats.

Authors:  Yan Gong; Zhan-Ping Chang; Ruo-Tong Ren; Shi-Hui Wei; Huan-Fen Zhou; Xiao-Fei Chen; Bao-Ke Hou; Xin Jin; Mao-Nian Zhang
Journal:  Cell Mol Neurobiol       Date:  2012-02-02       Impact factor: 5.046

Review 5.  Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy.

Authors:  David J Ramsey; G B Arden
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

6.  Multifocal VEP (mfVEP) reveals abnormal neuronal delays in diabetes.

Authors:  Brian E Wolff; Marcus A Bearse; Marilyn E Schneck; Shirin Barez; Anthony J Adams
Journal:  Doc Ophthalmol       Date:  2010-08-25       Impact factor: 2.379

7.  Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy.

Authors:  M Garcia-Ramírez; C Hernández; M Villarroel; F Canals; M A Alonso; R Fortuny; L Masmiquel; A Navarro; J García-Arumí; R Simó
Journal:  Diabetologia       Date:  2009-10-13       Impact factor: 10.122

8.  Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase.

Authors:  Chieh Allen Lee; Guangyuan Li; Mansi D Patel; J Mark Petrash; Beth Ann Benetz; Alex Veenstra; Jaume Amengual; Johannes von Lintig; Christopher J Burant; Johnny Tang; Timothy S Kern
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-02       Impact factor: 4.799

Review 9.  Corticosteroid use for diabetic macular edema: old fad or new trend?

Authors:  Michael W Stewart
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 10.  Neuroprotection in diabetic retinopathy.

Authors:  Cristina Hernández; Rafael Simó
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.